Misonix to Present at Sidoti & Company 2011 Micro Cap Conference
FARMINGDALE, N.Y., Jan. 3, 2011 - Misonix, Inc. (Nasdaq: MSON), a medical device company that designs, manufactures, and markets innovative therapeutic ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced today that Michael A. McManus, Jr., President and Chief Executive Officer, and Richard Zaremba, Chief Financial Officer, are scheduled to present at the Sidoti & Company 2011 Micro Cap Conference being held in New York City on January 10, 2011. Misonix's presentation is scheduled for 9:20 a.m. EST at the Grand Hyatt New York, located at 109 East 42nd Street at Grand Central Terminal.
Investors will also be able to arrange one-on-one meetings with Misonix in advance. The exclusive event is available to on-site attendees only. For additional information or to schedule a one-on-one meeting with Misonix at this event, please contact Kevin McGrath at kevin@cameronassoc.com/212-245-4577 or Justin Ruiss at jruiss@sidoti.com/212-453-7008.
A copy of the management presentation will be posted at: www.misonix.com.
About Misonix:
Misonix, Inc. designs, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.
SOURCE Misonix, Inc.
CONTACT:
Misonix Contact:
Richard Zaremba,
+1-631-694-9555,
invest@misonix.com;
Investor Relations Contact:
Kevin McGrath,
Cameron Associates, Inc.,
+1-212-245-4577,
Kevin@cameronassoc.com
Web Site: www.misonix.com
